loadpatents
Patent applications and USPTO patent grants for Pichler; Arthur.The latest application filed is for "co-crystal of an orally available hif prolyl hydroxylase inhibitor".
Patent | Date |
---|---|
Co-crystal of an orally available HIF prolyl hydroxylase inhibitor Grant 11,192,860 - Lengauer , et al. December 7, 2 | 2021-12-07 |
Storage stable composition comprising rifaximin alpha Grant 10,842,782 - Schwarz , et al. November 24, 2 | 2020-11-24 |
Co-Crystal of an Orally Available Hif Prolyl Hydroxylase Inhibitor App 20200262792 - Lengauer; Hannes ;   et al. | 2020-08-20 |
Storage Stable Composition Comprising Rifaximin Alpha App 20190008838 - Schwarz; Franz Xaver ;   et al. | 2019-01-10 |
1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form Grant 9,732,053 - Hotter , et al. August 15, 2 | 2017-08-15 |
Crystalline forms of ceftaroline fosamil Grant 9,534,004 - Wieser , et al. January 3, 2 | 2017-01-03 |
1-[2-(2,4-dimethylphenylsulfanyl) Phenyl]piperazine Acetate In Crystalline Form App 20160289202 - HOTTER; Andreas ;   et al. | 2016-10-06 |
Novel Crystalline Forms Of Ceftaroline Fosamil App 20160200750 - Wieser; Josef ;   et al. | 2016-07-14 |
Crystalline form of rivaroxaban dihydrate Grant 9,266,868 - Ludescher , et al. February 23, 2 | 2016-02-23 |
Crystal forms of saxagliptin Grant 9,260,389 - Pichler , et al. February 16, 2 | 2016-02-16 |
Method of preparing polymorphic pure form A of bazedoxifene acetate Grant 9,062,031 - Pichler , et al. June 23, 2 | 2015-06-23 |
Method Of Preparing Polymorphic Pure Form A Of Bazedoxifene Acetate App 20140294962 - Pichler; Arthur ;   et al. | 2014-10-02 |
Polymorph of linagliptin benzoate Grant 8,785,455 - Hotter , et al. July 22, 2 | 2014-07-22 |
Crystal Forms Of Saxagliptin App 20140200252 - Pichler; Arthur ;   et al. | 2014-07-17 |
Polymorph Of Linagliptin Benzoate App 20140121225 - Hotter; Andreas ;   et al. | 2014-05-01 |
Pharmaceutical compositions containing a crystalline form of posaconazole Grant 8,563,555 - Wieser , et al. October 22, 2 | 2013-10-22 |
Crystalline Form Of Rivaroxaban Dihydrate App 20130245017 - Ludescher; Johannes ;   et al. | 2013-09-19 |
Crystalline form C of tigecycline dihydrochloride and methods for its preparation Grant 8,513,224 - Hotter , et al. August 20, 2 | 2013-08-20 |
Crystalline form of posaconazole Grant 8,435,998 - Wieser , et al. May 7, 2 | 2013-05-07 |
Crystalline Forms Of Tigecycline Hydrochloride App 20130012481 - Wieser; Josef ;   et al. | 2013-01-10 |
Crystalline forms of tigecycline hydrochloride Grant 8,252,946 - Wieser , et al. August 28, 2 | 2012-08-28 |
Crystalline Form Of Posaconazole App 20120101277 - Wieser; Josef ;   et al. | 2012-04-26 |
Crystal Forms Of Saxagliptin App 20120088808 - Pichler; Arthur ;   et al. | 2012-04-12 |
Crystalline Form C Of Tigecycline Dihydrochloride And Methods For Its Preparation App 20120022025 - Hotter; Andreas ;   et al. | 2012-01-26 |
Antibiotic Compounds App 20110124893 - Decristoforo; Martin ;   et al. | 2011-05-26 |
Pharmaceutical Compositions Containing A Crystalline Form Of Posaconazole App 20110105525 - Wieser; Josef ;   et al. | 2011-05-05 |
Crystalline Forms Of Tigecycline Hydrochloride App 20110105772 - Wieser; Josef ;   et al. | 2011-05-05 |
A Crystalline Form Of Posaconazole App 20110065722 - Wieser; Josef ;   et al. | 2011-03-17 |
Organic Compounds App 20110015191 - Ludescher; Johannes ;   et al. | 2011-01-20 |
Novel Solvate App 20100256402 - Hotter; Andreas ;   et al. | 2010-10-07 |
Method For Salt Preparation App 20100204470 - Wieser; Josef ;   et al. | 2010-08-12 |
Crystalline Solid Forms App 20100160264 - Wieser; Josef ;   et al. | 2010-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.